GENE ONLINE|News &
Opinion
Blog

Precision Oncology
Kinnate Buys Back $24 Million Worth Of Shares From China Venture Kinnjiu
2023-02-22
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
China’s Berry Oncology Secures $99.15 Million in Series B1, Sets Industry Record for Highest Overall Capital Raised
2021-08-06
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
10 Precision Oncology Companies to Look Out for
2021-05-27
Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
AstraZeneca, Geneseeq Sign Collaborative Deal to Build Bio Center in China
2021-04-29
Illumina Looks to Consolidate NGS Market in APAC Region, Collaborates with Geneseeq to Develop IVD Kits in China
2021-03-21
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
LATEST
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
2023-03-28
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
2023-03-28
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
2023-03-27
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Scroll to Top